FEBRUARY 2023LIFE SCIENCES REVIEW5CXO INSIGHTSNEXT GENERATIONSEQUENCINGTOP 10SOLUTIONS PROVIDERS - 2023FEATURED COMPANIESMolecular InstrumentsAneesh Acharya,Ph.D., Vice President of Commercial2324Challenges And Opportunities ForAI In Drug DiscoveryRobert J. Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.19Improving Minimal Residual Disease Detection Using NGSSteven Henck, PhD, Vice President of R&D, Integrated DNA Technologies22Accelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsHua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai LabArtificial Intelligence and the Healthcare IndustryKelly H. Zou, PhD., PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris2826The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma IndustryPaul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations, Astellas Pharma US, Inc.Dante GenomicsMattia Capulli,CSO18Andrea Riposati,CEOSeqMaticLen Goren, CEO27Kelvin Chan, VP of Technology
< Page 4 | Page 6 >